Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Oct;38(1):141–146. doi: 10.1128/iai.38.1.141-146.1982

Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.

T R Cate, R B Couch
PMCID: PMC347709  PMID: 7141686

Abstract

Four live influenza A/Victoria/75 (H3N2) recombinant virus vaccines were administered intranasally to a total of 50 volunteers who had little or no detectable serum neutralizing antibody. A recombinant with ts-1[E] having a 38 degrees C shut-off temperature caused febrile reactions or systemic reactions or both in 21% of the volunteers, but one with ts-1A2 having a 37 degrees C shut-off temperature caused no illness. Two recombinants prepared with cold-adapted A/Ann Arbor/6/60 caused 9% febrile reactions or systemic reactions or both. Virus shedding occurred in a minority of the 50 volunteers, but 90% developed a serum neutralizing antibody response. Wild-type A/Victoria/75 virus challenge of 34 of the vaccinated volunteers and 12 others who had had prior natural A/Victoria/75 virus infection revealed similar and significant protection when compared with the 96% infection and 68% febrile illness or systemic illness or both observed in 25 unvaccinated volunteers with little or no serum antibody. These results encourage continued efforts toward development of live influenza virus vaccines.

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aymard-Henry M., Coleman M. T., Dowdle W. R., Laver W. G., Schild G. C., Webster R. G. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ. 1973;48(2):199–202. [PMC free article] [PubMed] [Google Scholar]
  2. Chanock R. M., Murphy B. R. Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease. Rev Infect Dis. 1980 May-Jun;2(3):421–432. doi: 10.1093/clinids/2.3.421. [DOI] [PubMed] [Google Scholar]
  3. Couch R. B., Douglas R. G., Jr, Fedson D. S., Kasel J. A. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. J Infect Dis. 1971 Nov;124(5):473–480. doi: 10.1093/infdis/124.5.473. [DOI] [PubMed] [Google Scholar]
  4. Cox N. J., Maassab H. F., Kendal A. P. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug;97(1):190–194. doi: 10.1016/0042-6822(79)90386-6. [DOI] [PubMed] [Google Scholar]
  5. Douglas R. G., Jr, Markoff L. J., Murphy B. R., Chanock R. M., Betts R. F., Hayden F. G., Levine M. M., Van Blerk G. A., Sotman S. B., Nalin D. R. Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus. Infect Immun. 1979 Oct;26(1):274–279. doi: 10.1128/iai.26.1.274-279.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Florent G. Gene constellation of live influenza A vaccines. Arch Virol. 1980;64(2):171–173. doi: 10.1007/BF01318021. [DOI] [PubMed] [Google Scholar]
  7. Hrabar A., Vodopija I., André F. E., Mitchell J. R., Maassab H. F., Hennessy A. V., Davenport F. M. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers. Dev Biol Stand. 1977 Jun 1;39:53–60. [PubMed] [Google Scholar]
  8. Kendal A. P., Cox N. J., Galphin J. C., Maassab H. F. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: independent segregation of temperature-sensitivity of virus replication from temperature-sensitivity of virion transcriptase activity during recombination of mutant A/Ann Arbor/6/60 with wild-type H3N2 strains. J Gen Virol. 1979 Aug;44(2):443–456. doi: 10.1099/0022-1317-44-2-443. [DOI] [PubMed] [Google Scholar]
  9. Mortiz A. J., Kunz C., Hofman H., Liehl E., Reeve P., Maassab H. F. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers. J Infect Dis. 1980 Dec;142(6):857–860. doi: 10.1093/infdis/142.6.857. [DOI] [PubMed] [Google Scholar]
  10. Murphy B. R., Chanock R. M., Levine M. M., van Blerk G. A., Berquist E. J., Douglas R. G., Betts R. F., Couch R. B., Cate T. R., Jr Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Infect Immun. 1979 Feb;23(2):249–252. doi: 10.1128/iai.23.2.249-252.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murphy B. R., Holley H. P., Jr, Berquist E. J., Levine M. M., Spring S. B., Maassab H. F., Kendal A. P., Chanock R. M. Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain. Infect Immun. 1979 Feb;23(2):253–259. doi: 10.1128/iai.23.2.253-259.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murphy B. R., Hosier N. T., Spring S. B., Mostow S. R., Chanock R. M. Temperature-sensitive mutants of influenza A virus: production and characterization of A/Victoria/3/75-ts-1[E] recombinants. Infect Immun. 1978 Jun;20(3):665–670. doi: 10.1128/iai.20.3.665-670.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Murphy B. R., Markoff L. J., Hosier N. T., Rusten H. M., Chanock R. M., Kendal A. P., Douglas R. G., Betts R. F., Cate T. R., Jr, Couch R. B. Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers. Infect Immun. 1978 Jun;20(3):671–677. doi: 10.1128/iai.20.3.671-677.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Murphy B. R., Tolpin M. D., Massicot J. G., Kim H. Y., Parrott R. H., Chanock R. M. Escape of a highly defective influenza A virus mutant from its temperature sensitive phenotype by extragenic suppression and other types of mutation. Ann N Y Acad Sci. 1980;354:172–182. doi: 10.1111/j.1749-6632.1980.tb27966.x. [DOI] [PubMed] [Google Scholar]
  15. Murphy B. R., Wood F. T., Massicot J. G., Chanock R. M. Temperature-sensitive mutants of influenza virus. XVI. Transfer of the two ts lesions present in the Udorn/72-ts-1A2 donor virus to the Victoria/3/75 wild-type virus. Virology. 1978 Jul 15;88(2):244–251. doi: 10.1016/0042-6822(78)90281-7. [DOI] [PubMed] [Google Scholar]
  16. Reeve P., Almond J. W., Felsenreich V., Pibermann M., Maassab H. F. Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. I. biologic, genetic, and biochemical characterization. J Infect Dis. 1980 Dec;142(6):850–856. doi: 10.1093/infdis/142.6.850. [DOI] [PubMed] [Google Scholar]
  17. Stuart-Harris C. From the National Institute of Allergy and Infectious Diseases. The present status of live influenza virus vaccine. J Infect Dis. 1980 Nov;142(5):784–793. doi: 10.1093/infdis/142.5.784. [DOI] [PubMed] [Google Scholar]
  18. Wright P. F., Ross K. B., Thompson J., Karzon D. T. Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med. 1977 Apr 14;296(15):829–834. doi: 10.1056/NEJM197704142961501. [DOI] [PubMed] [Google Scholar]
  19. Wright P. F., Sell S. H., Shinozaki T., Thompson J., Karzon D. T. Safety and antigenicity of influenza A/Hong Kong/68-ts-1 (E) (H3N2). J Pediatr. 1975 Dec;87(6 Pt 2):1109–1116. doi: 10.1016/s0022-3476(75)80123-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES